About Pfizer, Inc. Common Stock
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance.
2BB score and signals
Pfizer, Inc. Common Stock’s current 2BB score is 51 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 39 | Low |
| Momentum | 48 | Stable |
| Financial strength | 66 | Strong |
| Quality | 100 | Very Strong |
| Risk | 33 | Low |
Company facts
| CEO | Albert Bourla |
| Headquarters | New York, New York, United States |
| Founded | 1849 |
| Employees | 75K |
| P/E ratio | 37.10 |
| 52-week range | $23.58 – $28.74 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-01 | — | 0.7165 | — | $17.06B |
| 2026-11-02 | — | 0.765 | — | $16.11B |
| 2026-08-04 | 0.77 | 0.6914 | $15.03B | $14.55B |
| 2026-05-05 | 0.75 | 0.7243 | $14.45B | $13.92B |
Related companies
